As shown in Fig. 1, there were 43 NBNC-AFP(-)-HCC patients and 62 NBNC-AFP(+)-HCC patients, which accounted for 1.6% (43/2591) and 2.4% (62/2591) of all patients, respectively. Here, AFP is linked to hepatocellular carcinoma.